TG THERAPEUTICS, INC. Restricted Cash and Investments
TG THERAPEUTICS, INC. (TGTX) had Restricted Cash and Investments of $1.30 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Investments
us-gaap:RestrictedCashAndInvestments · last filed 2026-02-27
- 2025-12-31: Restricted Cash and Investments $1.30M.
- 2024-12-31: Restricted Cash and Investments $1.30M.
- 2023-12-31: Restricted Cash and Investments $1.30M.
- 2022-12-31: Restricted Cash and Investments $1.30M.
| Period end | Restricted Cash and Investments | Restricted Cash and Investments as first filed |
|---|---|---|
| 2025-12-31 | $1.30M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $1.30M 10-K · filed 2025-03-03 | |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $1.30M 10-K · filed 2023-03-01 | |
| 2021-12-31 | $1.30M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $1.30M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.30M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.30M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.30M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.30M 10-K · filed 2021-03-01 | |
| 2019-06-30 | $1.20M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.30M 10-K · filed 2020-03-02 | $600.00K 10-K · filed 2019-03-01 |
| 2018-09-30 | $1.20M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.20M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $600.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $600.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $600.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $600.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $600.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $600.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $600.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $600.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $600.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $600.00K 10-Q · filed 2016-11-09 | |
| 2015-09-30 | $600.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $600.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $600.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $600.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |